Search

everythinglearnresearchcommunity

for

Search:↓

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

A new method accurately measures long-term hormone levels in hair.

Hair cortisol measurement is a promising, non-invasive tool for monitoring cortisol exposure over time.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Free Testosterone Index, bioavailable testosterone, and androstenedione are the most accurate for diagnosing excess male hormones in PCOS.

Thyroid and reproductive hormones, BMI, and excess hair are linked in Iraqi women with PCOS.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Physical exams are important in hair loss diagnosis, considering cosmetic history, systemic diseases, and classifying alopecia types.

Human hair can be used to measure reproductive hormones.

Women aged 21-26 have a higher rate of PCOS.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Doctors should watch for and treat hormonal issues in obese patients beyond just diabetes.

Young women with hair loss should get hormone, thyroid, iron, and vitamin D tests, plus clinical checks.

Young women with hair loss should get hormone, thyroid, iron, and vitamin D tests, plus clinical checks.

Human scalp hair follicles can produce and respond to several hormones, affecting hair growth and pigmentation.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Steroid hormones can be preserved in ancient hair, revealing insights into past health and fertility.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

The case emphasizes the need for careful screening in children for insulin resistance and related conditions.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Hair hormone levels can indicate obesity-related changes and are useful for research and clinical practice.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

New diabetes tech and therapies improve care for endocrine disorders.